KLK10 and acute lymphoblastic leukemia: Univariate logistic regression analysis demonstrated that patients with reduced KLK10 mRNA expression levels establish a significant prognostic biomarker for ALL (crude odds ratio [OR] = 0.0228, 95% CI [0.0008851–0.2299], p < 0.0001).